Back

KCNQ1 V141M and Short QT Syndrome: Are we dealing with a different entity?

29 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Risk of Sudden Cardiac Death in Patient with Ion Channel Disorders Clinical ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Gabriela Paola Garcia Ordonez

Universidad de Guadalajara, Guadalajara (Mexico)

5 More presentations in this session

Presentation thumbnail
ICD implantation and device therapy: Fabry vs hypertrophic cardiomyopathy
Doctor R. Vijapurapu (Stoke-on-Trent, GB)
Abstract Slides
Presentation thumbnail
Long-term efficacy and safety of hydroquinidine in patients with Brugada syndrome
Doctor F. Angelini (Turin, IT)
Abstract Slides
Presentation thumbnail
Splice site mutation of LMNA causes severe dilated cardiomyopathy via strong dominant reduction of total lamin expression
Doctor K. Kato (Otsu, JP)
Abstract Slides
Presentation thumbnail
Role of an extensive diagnostic work-up in the detection of concealed cardiomyopathies in athletes with premature ventricular complexes and implications for sports' eligibility assessment
Doctor P. Compagnucci (Ancona, IT)
Abstract Slides
Presentation thumbnail
Molecular mechanism of a new cardiac syndrome associated with a regulatory element deletion of chromosome 4q25
Ms M. Baudic (Nantes, FR)
Abstract Slides

Access the full session

Session thumbnail
Risk of Sudden Cardiac Death in Patient with Ion Channel Disorders

The Event

Event poster

ESC Congress 2020

29 August 2020 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Systematic Evaluation of KCNQ1 variant using ACMG/AMP Guidelines and Risk Stratification in Long QT Syndrome Type 1
28 August 2020
thumbnail
Congress Presentation
A ventricular conduction delay phenotype and its outcome in heart failure with preserved ejection fraction
21 May 2023
thumbnail
Congress Presentation
Efficacy and limitations of quinidine therapy in patients with Brugada Syndrome
3 September 2019
thumbnail
Congress Presentation
Metabolic treatment of an electrical disease? - Beneficial APD/QT prolongation by L-Carnitine in transgenic SQT1 rabbit models
29 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources